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Abstract
Background Skin and soft tissue infections are a common
admission diagnosis to emergency department (ED) obser-
vation units (OU). Little is known about which patients fail
OU treatment.
Aims This study evaluates clinical factors of skin or soft
tissue infections associated with further inpatient treatment
after OU treatment failure.
Methods A structured retrospective cohort study of consec-
utive adults treated for abscess or cellulitis in our OU from
April 2005 to February 2006 was performed. Records were
identified using ICD-9 codes and were abstracted by two
trained abstractors using a structured data collection form.
Significant variables on univariate analysis P<0.1 were
entered into a multivariate logistic regression.
Results A total of 183 patient charts were reviewed. Four
patients with a non-infectious diagnosis were excluded,
leaving 179 patients. The median age was 41 (interquartile
range: 20–74). Following observation treatment, 38% of
patients required admission. The following variables were
evaluated for association with failure to discharge home:
intravenous drug use, gender, a positive community-
acquired methicillin-resistant Staphylococcus aureus cul-
ture, age, presence of medical insurance, drainage of an
abscess in the ED, diabetes and a white blood cell count
(WBC) greater than 15,000. Following multivariate analy-
sis only female gender odds ratio (OR) 2.33 [95%
confidence interval (CI): 1.06–5.15] and WBC greater than
15,000 OR 4.06 (95% CI: 1.53–10.74) were significantly
associated with failure to discharge.
Conclusions Among OU patients treated for skin and soft
tissue infections, women were twice as likely to require
hospitalization and patients with a WBC>15,000 on
presentation to the ED, regardless of gender, were 4 times
more likely to require hospitalization.
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Introduction
The epidemiology of skin and soft tissue infections seen in
the emergency departments (ED) across the USA has
changed considerably over the past 5 years. Skin and soft
tissue infections are a common illness affecting the general
population with an incidence of 24.6 per 1,000 person-
years [1]. The emergence of community-acquired methicil-
lin-resistant Staphylococcus aureus (CA-MRSA) may re-
quire a re-evaluation of treatment and disposition decisions.
Until recently, the majority of immunocompetent
patients with cellulitis were treated on an outpatient basis
with oral antibiotics alone. Although no definitive criteria
existed to assist in determining which patients required
inpatient therapy, general recommendations included ad-
mission for those who were immunocompromised, neutro-
paenic and exhibited signs of systemic toxicity or fasciitis
[2]. For the majority of patients, clinicians must rely on
their own experience and judgment when determining
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of community-acquired methicillin-resistant infections not-
ed that factors such as body part affected, diabetes and
temperature were associated with the need for inpatient
therapy [3–5].
A new option for treatment of these patients includes
observation units [5, 6]. Observation units are often managed
and staffed by emergency physicians and offer an alternative
to inpatient hospital admission. These units have become
more popular and are expected to become more prevalent as
studies have shown significant cost savings with their use
[7–10].
We attempted to clarify the role of ED observation units
in the treatment of skin and soft tissue infections in the era
of CA-MRSA by identifying clinical factors of skin or soft
tissue infections associated with the need for further
inpatient therapy after treatment in an ED and observation
unit (OU).
Methods
The study was conducted at a large urban county hospital
with an ED census of approximately 84,000 visits. The OU
is a 14-bed unit staffed 24 h a day 7 days a week and
managed by board certified or residency trained board
prepared emergency physicians and internal medicine
physicians.
Information was collected retrospectively on a cohort of
consecutive adults age 18 or older admitted to our ED OU
from April 2005 to February 2006 for treatment of soft
tissue infection, with an international diagnostic code (ICD-
9 code) 680.0 through 685.1. These codes remained valid
for soft tissue infections and did not change from the 2005
to 2006 edition. Patients who were placed in the OU for a
soft tissue infection but discharged with a different
inflammatory condition (i.e. acute gouty arthritis) were
excluded from the study. Patients who were admitted for
another major condition that would require observational
care, for example heart failure and cellulitis, were not
included.
Records were abstracted by two trained researchers
using structured review with a standardized abstraction
form. The abstractors were not blinded to patient disposi-
tion when collecting data.
All data were abstracted from one of two sources. The
initial source was an electronic medical record system
(EPIC Systems Corporation, Madison, WI, USA) which
contains all ED and outpatient clinic records, inpatient test
results, operative reports, culture results, laboratory values
and discharge summaries. If data were missing from the
computerized chart, the original chart record was reviewed
from a second computerized system (OnBase, Hyland
Software Inc., Cleveland, OH, USA) which contains the
optically scanned paper records from the patient’s visit. A
20% sample of medical records was reviewed by a second
trained abstractor with each abstractor blinded to the other’s
results. Reviewer agreement was calculated using Cohen’s
κ with 95% confidence intervals (CI).
The ED encounter during which the patients were
admitted to the OU was considered the index visit. If the
patient had a prior clinic or ED visit within 1 week of their
index ED visit, as determined by their hospital chart, that
appointment was also reviewed to determine if the skin
infection was present and treated with antibiotics. All
clinical encounters that occurred after the index visit were
reviewed as well. Patients who were readmitted for
cellulitis in the same location as the index visit within
7 days of discharge from the hospital or ED were noted as
readmissions. These patients were tracked to see if poor
outcomes occurred such as death and sepsis, or if length of
hospitals stays were different from those patients admitted
after observation treatment.
Data collected included demographics, initial vital signs,
duration of symptoms, body part affected, presence of
lymphangitis if mentioned, white blood cell count, absolute
neutrophil count, percent bandaemia present, haemoglobin,
haematocrit, initial glucose, erythrocyte sedimentation rate
and C-reactive protein. Blood culture results, when per-
formed, were recorded.
All antibiotics given prior to the index visit, at the index
visit and upon discharge from the OU were recorded as
well. Compliance was not assessed and therefore not
addressed.
Outcomes were recorded as discharge home from the
OU, admission to the floor, admission to operating room or
admission to intensive care unit. Disposition decisions were
based on individual physician clinical judgment. Disposi-
tion from the OU generally occurred within 24 h of
admission to the OU in agreement with the Department of
Health and Human Services recommendations [11]. It is the
policy of our OU that all patients must be out of the clinical
decision unit (CDU) within 48 h. In our institution, the
number of patients in the OU for greater than 48 h is less
than 1% of all OU patients. Any hospitalization over the
next 7 days to either the hospital or OU was recorded as a
readmission. Length of hospitalization was recorded in days
based on number of calendar days beginning with admis-
sion from the OU to the hospital until discharge. Repeat ED
visits and subsequent discharges home were not character-
ized as readmissions.
The timing of incision and drainage was recorded if
performed. Wound culture results from the infected body
part were recorded. Wound culture specimens were pro-
cessed at our hospital laboratory per reported standard
techniques [12]. D-zone disk diffusion tests were performed
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All data were entered into a database for analysis by the
primary investigator (JS), using Stata 8.0 (StataCorp,
College Station, TX, USA). Chi-squared tests and Student’s
t-test were used where appropriate.
Amoremoderateleukocytosislevel of15,000waschosen
a priori.We believed a more moderateleukocytosis would be
more predictive of severe disease. This value has been used
in other studies to assist in estimating severity of disease
[14–15]. Variables thought to be clinically related to
disposition decisions from the OU or found to be relevant
in prior research were first evaluated by a fitted model for
univariate analysis. Variables fitted in the univariate analysis
but not used in the logistic regression due to lack of
significance include African American and Hispanic race,
use of a non-beta-lactam in the ED and fever. Those found to
be significant were entered into a logistic regression. The
variables used in the logistic regression included gender,
intravenous drug use, a positive CA-MRSA culture, age,
health insurance, incision and drainage procedure, diabetes
and a leukocytosis greater than 15,000. Our institution’s
Internal Review Board reviewed the proposed study and
allowed for a waiver of informed consent.
Results
A total of 183 patient charts were reviewed for inclusion
into the study. Four patients who were admitted to the OU
with a diagnosis of skin or soft tissue infection and were
later discharged with non-infectious conditions were ex-
cluded from the reviews providing a total of 179 patients.
Demographic characteristics are shown in Table 1. Forty
patients (22%) were prescribed antibiotics prior to their
index visit. The median time of duration of symptoms was
3.5 days [interquartile range (IQR): 2–6 days]. Although
the most common site of infection for patients requiring
further inpatient treatment in the OU was the leg, patients
with hand infections were most likely to require inpatient
treatment (Table 2). During the study period 2,290 (1.5%)
patients were treated in the ED for skin and soft tissue
infections; 179 (7.8%) were admitted to the OU and 801
(35.0%) were admitted directly to the hospital for care. A
total of 64 (35.8%) of the wound cultures grew CA-MRSA,
which vastly outnumbered all other bacterial pathogens
grown from this sample. The sensitivities for these isolates
are shown in Table 3. Incision and drainage procedures
were peformed in 84 (47%) of the patients in the ED. Of
these patients 18 (11%) required a second drainage
procedure after their OU treatment; 11 (6%) of the patients
had an initial incision and drainage procedure performed
after their OU stay.
In the population admitted to the OU 33 (22%) had
received antibiotics within 1 week prior to ED presentation.
The most commonly used antibiotic class were beta-lactams
used in 20 (11.1%) of the patients. Sulphonamide/folate
antagonists were used by 14 (7.8%) of the patients.
Quinolones, macrolides, tetracyclines and lincosamides
were each used in <3% of subjects prior their ED index
visits. The list of antibiotics used in the ED can be seen in
Table 4. Of the patients, 18 (10%) received more than one
antibiotic in the ED. The antibiotics used in the ED were
Table 1 Demographic characteristics
Characteristic N=179 (%)
Race
Caucasian 112 (62.6)
African American 49 (27.4)
Hispanic 16 (8.9)
Asian 2 (1.1)
Sex
Male 112 (62.6)
Age
18–39 82 (45.8)
40–59 78 (43.6)
60 or greater 19 (10.6)
Health history
Current smoker 91 (52)
IVDA 26 (14.8)
Diabetes 27 (15.1)
HIV 4 (2.2)
Temperature (F) at ED triage
a 98.1 (97.2–99.3)
WBC (cells/mm
3)
a 10.73 (8.3–13.5)
Abscess drained in ED 84 (47.0)
Abscess drained after OU discharge 11 (6.1)
Insurance
Medicare 22 (12.3)
Medicaid 32 (17.9)
Commercial 23 (12.9)
None 101 (56.4)
Other 2 (1.1)
aMedian with interquartile range
IVDA intravenous drug abuse, HIV human immunodeficiency virus
Table 2 Infection site based
on area of body affected Location Subjects, no. (%)
Face/head 16 (8.9)
Torso 9 (5.0)
Hand 26 (14.5)
Arm 40 (22.4)
Foot 23 (12.9)
Leg 68 (38.0)
Buttocks 10 (5.6)
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treating physician.
Of the patients who had documented CA-MRSA
infections, 19/64 (30%) were discharged from the OU with
a prescription for a beta-lactam antibiotic; 68 (38%) of the
OU patients were admitted for further inpatient treatment.
Only 4 (5.3%) of the 76 patients from whom blood cultures
were obtained grew bacteria: MRSA in one and methicillin-
sensitive Staphylococcus aureus (MSSA) in another and
two contaminated culture sets. Wound cultures from each of
these patients yielded the same organism. We found a high
prevalence of CA-MRSA infection in this population. If
contaminants are excluded, CA-MRSA constituted 78% of
all positive wound cultures. One patient was admitted to the
intensive care unit and one was admitted to the operating
room for surgical drainage of an abscess. No patients died
prior to discharge or within 7 days of discharge.
Sixty-eight patients (38%) failed observation treatment
and required inpatient admission for further therapy. Ten
(5.6%) of the patients discharged from the OU were later
hospitalized within 7 days of OU discharge for further
treatment of their infection. The median length of stay for
patients immediately failing observation treatment was
3 days (range: 1–17) and the median length of stay of
patients who were discharged after observation treatment
and later admitted was 3 days (range: 1–6).
Length of total treatment time from ED presentation to
disposition from the OU was the same for patients who
were successfully treated and those who required further
inpatient treatment [21.6 h (IQR: 17.9–26.0 h) vs 21.6 h
(IQR: 16.5–25 h)].
Women were twice as likely to require admission [odds
ratio (OR): 2.34 (1.06–5.16)] and patients with a leukocy-
tosis greater than 15,000 were four times more likely to
require admission [OR: 4.06 (1.53–10.74)] after adjusting
for gender, intravenous drug use, a positive CA-MRSA
culture, age, health insurance, incision and drainage
procedure, diabetes and a leukocytosis greater than
15,000. In this sample 28 (16%) of the patients had a
leukocytosis greater than 15,000.
Discussion
Our data indicated that among patients admitted to an OU
for skin and soft tissue infections, women and patients with
a leukocytosis of greater than 15,000 were more likely to
require admission after observation treatment has ended.
In this study a white blood cell count of greater than
15,000 was associated with a rate of hospital admission
four times greater than baseline. This leukocytosis is likely
reflective of more severe illness especially given the high
proportion of CA-MRSA in our cohort. It remains uncertain
how emergency physicians would use this knowledge in the
management of patients with skin and soft tissue infections.
Other variables which might intuitively be associated
with a higher likelihood of admission such as a positive
CA-MRSA culture, diabetes or advanced age were not
significantly associated with admission on multivariate
analysis. This could be related to selection bias created by
the limited inclusion of these patients for observation
treatment or it is possible that these patients were more
likely to be selected for observation treatment.
Gender disparity seen in this sample is interesting. While
women were the minority of patients admitted to the OU,
they were twice as likely as men to fail treatment and
require hospital admission. The reason behind this is
unclear. It does not appear that women were more likely
to seek treatment later in the course of their illness. No
other factors such as length of hospital admission seem to
signify that these infections in women were more signifi-
cant than in men. There does not appear to a major
difference in pathogens between genders but this is only an
assumption and was not an intended measure of this study.
A prior study evaluating hospitalized patients with cellulitis
found females to be associated with earlier discharge and a
lower risk of death. The authors did not offer specific
reasons for this gender difference but suggest that co-
morbid conditions increase the risk of complications [16].
Table 3 Antibiotic susceptibility (%) among MRSA isolates
Antibiotic MRSA (N=64)
Oxacillin 0
Erythromycin 4.7
Levofloxacin 70.3
a
Tetracycline 88.9
Clindamycin 90.6
b
TMP/SMX 100
Vancomycin 100
Rifampin 100
aFifteen isolates showed intermediate resistance to levofloxacin
bFour isolates showed inducible resistance to clindamycin
TMP/SMX trimethoprim-sulphamethoxazole
Table 4 ED antibiotics
Antibiotic classification Subjects, no. (%)
a
Beta-lactam 86 (48%)
Vancomycin 57 (32%)
Lincosamide 40 (22%)
Sulphonamide/folate antagonist 11 (6.1%)
Tetracycline 4 (2.2%)
Quinolone 1 (0.6%)
a10% of patients received more than one antibiotic
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severity of illness making generalization with our OU
population problematic. Further research will be needed to
determine if this is a local phenomenon or a trait of the
management of this disease.
A surprisingly high number of blood cultures were
performed in this population. As seen in other studies, the
utility of this test was exceedingly low and this practice
does not appear to be in line with the recommendations of
the Infectious Diseases Society of America [2, 17, 18]. The
admission rate for patients treated in the OU with skin and
soft tissue infections of 38% is twice as high as the
admission rate after treatment in our OU for other
conditions such as chest pain, asthma and pneumonia. Our
admission rate for cellulitis was also higher than published
rates from other ED OUs [5].
The implications of the high prevalence of CA-MRSA
wounds for antibiotic treatment of these infections are
profound. Based on our results, patients with purulence
present on exam and with a concomitant cellulitis should be
provided antibiotics that cover CA-MRSA, such as trimeth-
oprim-sulphamethoxazole, rifampin or clindamycin (which
are all greater than 90% active against CA-MRSA),
although clindamycin resistance of up to 60% has been
found in New York City isolates [19]. For patients with a
high suspicion of CA-MRSA, quinolones, macrolides and
beta-lactams should be avoided as solitary coverage.
Almost one third of patients were discharged on beta-
lactams and of those the majority did well after discharge,
suggesting that incision and drainage may provide suffi-
cient treatment for abscess. This finding is consistent with
results from other investigators [19–21]. An answer to this
question specifically for CA-MRSAwould require prospec-
tive study to determine which if antibiotics are truly
needed.
Limitations of this study include its retrospective design.
We were unable to include patients who were admitted
directly to the hospital from the ED and were discharged
within 24 h. This study was not intended to elucidate factors
used by physicians in their decision to admit or discharge.
Inherent problems may have occurred with data entry as the
chart was produced. Although unlikely, incorrect DRG
coding may have accidentally excluded some patients. The
computerized charting system used has been suggested to
improve data collection of both coded diagnosis and patient
data [22, 23].
The population studied here contained patients consid-
ered to have moderate illness and may not be representative
of all patients arriving to the ED with skin and soft tissue
infections. We did not differentiate infections as nosocomial
or health care-associated infections. As this was a retro-
spective study we could not detail if a patient was admitted
to a hospital 30 days prior to their ED visit. Our OU patient
population does not include nursing home patients. This
population often has multiple complex medical and social
issues which are not best served in our OU so these patients
are typically admitted to the hospital. It would be incorrect
to generalize these results for that population.
We did not perform genetic testing of our CA-MRSA
isolates to determine genetic identification. Moran et al.
demonstrated that risk factors for hospital-acquired infec-
tion do not correlate with genetic typing when performed.
In their study, one fourth of patients possessed risk factors
for hospital-acquired MRSA, yet 99% were infected with
the community-acquired strain [19].
The timing of this study occurred as the emergence of
CA-MRSA was becoming more widely known. It is not
known if a greater percentage of ED physicians using non-
beta-lactam antibiotics would have reduced admission.
As with all retrospective studies, we were unable to
estimate how many patients discharged from the ED or OU
sought further care at other institutions.
In conclusion, leukocytosis greater that 15,000 and
female gender were the only variables associated with a
need for further inpatient therapy after an ED observation
treatment period for patients with skin and soft tissue
infections. The emergence of CA-MRSA is changing how
we manage skin and soft tissue infections. Increased sur-
veillance and knowledge of the clinicians’ own local bacte-
rial resistance profiles are necessary to provide appropriate
care for patients.
In conclusion we found that the majority of patients with
moderate skin and soft tissue infections can successfully be
treated in an ED observation setting, although the discharge
rate after observation treatment is lower than other diseases
such as chest pain [24–26]. Traditional risk factors for
poorer outcome, including diabetes and intravenous drug
abuse, in patients with skin infections did not significantly
increase the odds of admission after observation treatment.
In our population only leukocytosis over 15,000 and female
gender significantly increased the odds of admission after
observation treatment. The clinical significance of this
would require further prospective studies.
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